Skip to main content
Download PDF
- Main
Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast
- Huang, Huaizhi;
- Couch, Ronan E;
- Karam, Rachid;
- Hu, Chunling;
- Boddicker, Nicholas;
- Polley, Eric C;
- Na, Jie;
- Ambrosone, Christine B;
- Yao, Song;
- Trentham-Dietz, Amy;
- Eliassen, A Heather;
- Penney, Kathryn;
- Brantley, Kristen;
- Bodelon, Clara;
- Teras, Lauren R;
- Hodge, James;
- Patel, Alpa;
- Haiman, Christopher A;
- John, Esther M;
- Neuhausen, Susan L;
- Martinez, Elena;
- Lacey, James V;
- O’Brien, Katie M;
- Sandler, Dale P;
- Weinberg, Clarice R;
- Palmer, Julie R;
- Bertrand, Kimberly A;
- Vachon, Celine M;
- Olson, Janet E;
- Ruddy, Kathryn E;
- Anton-Culver, Hoda;
- Ziogas, Argyrios;
- Goldgar, David E;
- Nathanson, Katherine L;
- Domchek, Susan M;
- Weitzel, Jeffrey N;
- Kraft, Peter;
- Dolinsky, Jill S;
- Pesaran, Tina;
- Richardson, Marcy E;
- Yadav, Siddhartha;
- Couch, Fergus J
- et al.
Published Web Location
https://doi.org/10.1158/1078-0432.ccr-24-1884Abstract
Purpose
To determine the relationship between germline pathogenic variants (PV) in cancer predisposition genes and the risk of ductal carcinoma in situ (DCIS).Experimental design
Germline PV frequencies in breast cancer predisposition genes (ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, PALB2, RAD51C, and RAD51D) were compared between DCIS cases and unaffected controls and between DCIS and invasive ductal breast cancer (IDC) cases from a clinical testing cohort (n = 9,887), a population-based cohort (n = 3,876), and the UK Biobank (n = 2,421). The risk of contralateral breast cancer (CBC) for DCIS cases with PV was estimated in the population-based cohort.Results
Germline PV were observed in 6.5% and 4.6% of women with DCIS in the clinical testing and population-based cohorts, respectively. BRCA1, BRCA2, and PALB2 PV frequencies were significantly lower among women with DCIS than those with IDC (clinical cohort: 2.8% vs. 5.7%; population-based cohort: 1.7% vs. 3.7%), whereas the PV frequencies for ATM and CHEK2 were similar. ATM, BRCA1, BRCA2, CHEK2, and PALB2 PV were significantly associated with an increased risk of DCIS (OR > 2.0), but only BRCA2 PV were associated with high risk (OR > 4) in both cohorts. The cumulative incidence of CBC among carriers of PV in high-penetrance genes with DCIS was 23% over 15 years.Conclusions
The enrichment of PV in ATM, BRCA1, BRCA2, CHEK2, and PALB2 among women with DCIS suggests that multigene panel testing may be appropriate for women with DCIS. Elevated risks of CBC in carriers of PV in high-penetrance genes with DCIS confirmed the utility of testing for surgical decision-making.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%